Literature DB >> 17250726

Neuro-Behçet's disease in Caucasians: a study of 22 patients.

F G Joseph1, N J Scolding.   

Abstract

Several analyses of the neurological features of Behçet's disease (BD) have concluded that there are significant racial differences in its clinical expression. Other series, however, failed to elicit such differences. We aimed to describe in this retrospective survey the frequency, nature and relationship to systemic disease of the neurological features in a cohort of BD patients of Caucasian origin. We searched hospital records from nine District General or Regional Centre hospitals in south-west Great Britain and identified 22 individuals of Caucasian ethnic origin with neuro-BD, with a mean of 10 years follow-up per patient - the largest 'western' case series with the longest period of follow-up reported. We found that presentation with neurological features was commoner in our patients (23%) than Middle Eastern series (3-10%). Seizures (27%) were likewise commoner (0-5%), as was optic neuritis (9% compared with 1-2%). Two patients developed movement disorders (chorea and parkinsonism), which have only been rarely reported. Of further clinical significance, we noted that non-neuropsychiatric features: oral ulceration, intraocular inflammation and skin lesions - were virtually always present or exacerbated during neurological complications. Ethnicity--or conceivably environment--may play a significant role in the manifestation of neurological BD.

Entities:  

Mesh:

Year:  2007        PMID: 17250726     DOI: 10.1111/j.1468-1331.2006.01613.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  25 in total

1.  Atypical manifestations in Brazilian patients with neuro-Behçet's disease.

Authors:  Lívia Almeida Dutra; Célio Roberto Gonçalves; Pedro Braga-Neto; José Luiz Pedroso; Alberto Alain Gabbai; Orlando Graziani Povoas Barsottini; Alexandre Wagner Silva de Souza
Journal:  J Neurol       Date:  2011-12-15       Impact factor: 4.849

Review 2.  Immunotherapies for Neurological Manifestations in the Context of Systemic Autoimmunity.

Authors:  Eleni I Kampylafka; Harry Alexopoulos; Marinos C Dalakas; Athanasios G Tzioufas
Journal:  Neurotherapeutics       Date:  2016-01       Impact factor: 7.620

Review 3.  Cerebral vasculitis in adults: what are the steps in order to establish the diagnosis? Red flags and pitfalls.

Authors:  P Berlit; M Kraemer
Journal:  Clin Exp Immunol       Date:  2014-03       Impact factor: 4.330

4.  Shedding light on vasculitis in Egypt: a multicenter retrospective cohort study of characteristics, management, and outcome.

Authors:  Doaa Hassan Sayed Attia; Rasha A Abdel Noor; Shaimaa Salah
Journal:  Clin Rheumatol       Date:  2019-02-09       Impact factor: 2.980

5.  Neuro-Behçet's Disease with Chorea.

Authors:  Selen Gür Özmen; Haşmet Hanağasi; Hakan Gürvit; Murat Emre; Gülşen Akman Demir
Journal:  Noro Psikiyatr Ars       Date:  2015-06-01       Impact factor: 1.339

Review 6.  Cerebral venous thrombosis in Behçet's disease: a systematic review.

Authors:  D Aguiar de Sousa; T Mestre; J M Ferro
Journal:  J Neurol       Date:  2011-01-06       Impact factor: 4.849

7.  Occurrence of ankylosing spondylitis and multiple sclerosis-like syndrome in a HLA-B27 positive patient.

Authors:  Andrea Mignarri; Maria Teresa Dotti; Carla Battisti; Ignazio Vallone; Antonio Federico
Journal:  Neurol Sci       Date:  2009-05-15       Impact factor: 3.307

8.  Epidemiology and clinical characteristics of Behçet's disease in the US: a population-based study.

Authors:  Kenneth T Calamia; Floranne C Wilson; Murat Icen; Cynthia S Crowson; Sherine E Gabriel; Hilal Maradit Kremers
Journal:  Arthritis Rheum       Date:  2009-05-15

Review 9.  Optic neuropathy in Behçet's syndrome.

Authors:  Desmond P Kidd
Journal:  J Neurol       Date:  2013-09-26       Impact factor: 4.849

Review 10.  Role of brain inflammation in epileptogenesis.

Authors:  Jieun Choi; Sookyong Koh
Journal:  Yonsei Med J       Date:  2008-02-29       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.